Casi Pharmaceuticals, INC. 3 Filing
Ticker: CASIF · Form: 3 · Filed: Apr 23, 2026 · CIK: 0001962738
| Field | Detail |
|---|---|
| Company | Casi Pharmaceuticals, INC. (CASIF) |
| Form Type | 3 |
| Filed Date | Apr 23, 2026 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 3 filing submitted by Casi Pharmaceuticals, INC. (ticker: CASIF) to the SEC on Apr 23, 2026.
Where can I view the full 3 filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Details
This Initial Statement of Beneficial Ownership (Form 3) was filed with the SEC on April 23, 2026 regarding CASI Pharmaceuticals, Inc. (CASIF). Form 3 filings establish the initial ownership position of company insiders when they first assume their role.